BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37122736)

  • 21. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis.
    Li X; Cai H; Cai Y; Zhang Q; Ding Y; Zhuang Q
    Front Immunol; 2021; 12():629854. PubMed ID: 34194423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential.
    Liu S; Liu C; Wang Q; Liu S; Min J
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of the prognostic model based on autophagy-associated genes in idiopathic pulmonary fibrosis.
    Fan G; Liu J; Wu Z; Li C; Zhang Y
    Front Immunol; 2022; 13():1049361. PubMed ID: 36578501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil-Related Gene Expression Signatures in Idiopathic Pulmonary Fibrosis: Implications for Disease Characteristic and Identification of Diagnostic Hub Genes.
    Lin Y; Lai X; Lei T; Qiu Y; Deng Q; Liu Q; Wang Z; Huang W
    J Inflamm Res; 2023; 16():2503-2519. PubMed ID: 37337515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine learning-based prediction of candidate gene biomarkers correlated with immune infiltration in patients with idiopathic pulmonary fibrosis.
    Zhang Y; Wang C; Xia Q; Jiang W; Zhang H; Amiri-Ardekani E; Hua H; Cheng Y
    Front Med (Lausanne); 2023; 10():1001813. PubMed ID: 36860337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.
    Bauer Y; Tedrow J; de Bernard S; Birker-Robaczewska M; Gibson KF; Guardela BJ; Hess P; Klenk A; Lindell KO; Poirey S; Renault B; Rey M; Weber E; Nayler O; Kaminski N
    Am J Respir Cell Mol Biol; 2015 Feb; 52(2):217-31. PubMed ID: 25029475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and immune characteristics of molecular subtypes related to fatty acid metabolism in idiopathic pulmonary fibrosis.
    Yang F; Ma Z; Li W; Kong J; Zong Y; Wendusu B; Wu Q; Li Y; Dong G; Zhao X; Wang J
    Front Nutr; 2022; 9():992331. PubMed ID: 36211517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis.
    Baran CP; Opalek JM; McMaken S; Newland CA; O'Brien JM; Hunter MG; Bringardner BD; Monick MM; Brigstock DR; Stromberg PC; Hunninghake GW; Marsh CB
    Am J Respir Crit Care Med; 2007 Jul; 176(1):78-89. PubMed ID: 17431224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
    Peng R; Sridhar S; Tyagi G; Phillips JE; Garrido R; Harris P; Burns L; Renteria L; Woods J; Chen L; Allard J; Ravindran P; Bitter H; Liang Z; Hogaboam CM; Kitson C; Budd DC; Fine JS; Bauer CM; Stevenson CS
    PLoS One; 2013; 8(4):e59348. PubMed ID: 23565148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
    Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
    Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deciphering the underlying mechanisms of Sanleng-Ezhu for the treatment of idiopathic pulmonary fibrosis based on network pharmacology and single-cell RNA sequencing data.
    Zhou X; Tan F; Zhang S; Zhang T
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37559532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cuproptosis-related diagnostic biomarkers in idiopathic pulmonary fibrosis.
    Wang Q; Shang Y; Li Y; Li X; Wang X; He Y; Ma J; Ning S; Chen H
    Medicine (Baltimore); 2024 Jan; 103(2):e36801. PubMed ID: 38215148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of metabolism-related hub genes in idiopathic pulmonary fibrosis.
    Zeng Y; Huang J; Guo R; Cao S; Yang H; Ouyang W
    Front Genet; 2023; 14():1058582. PubMed ID: 36923791
    [No Abstract]   [Full Text] [Related]  

  • 36. Anoikis and SPP1 in idiopathic pulmonary fibrosis: integrating bioinformatics, cell, and animal studies to explore prognostic biomarkers and PI3K/AKT signaling regulation.
    Liao Y; Yang Y; Zhou G; Chen L; Yang Y; Guo S; Zuo Q; Zou J
    Expert Rev Clin Immunol; 2024 Jun; 20(6):679-693. PubMed ID: 38318669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
    Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
    Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of tripartite motif (TRIM) family gene signature from bronchoalveolar lavage cells in idiopathic pulmonary fibrosis.
    Zhou M; Ouyang J; Zhang G; Zhu X
    BMC Pulm Med; 2022 Dec; 22(1):467. PubMed ID: 36474231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies.
    Dai X; Yang Z; Zhang W; Liu S; Zhao Q; Liu T; Chen L; Li L; Wang Y; Shao R
    Front Med (Lausanne); 2022; 9():959010. PubMed ID: 36507532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis.
    Uchida M; Shiraishi H; Ohta S; Arima K; Taniguchi K; Suzuki S; Okamoto M; Ahlfeld SK; Ohshima K; Kato S; Toda S; Sagara H; Aizawa H; Hoshino T; Conway SJ; Hayashi S; Izuhara K
    Am J Respir Cell Mol Biol; 2012 May; 46(5):677-86. PubMed ID: 22246863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.